BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility
Go back to BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.38 | 52 Week High | $10.98 | |||
| Open | $9.38 | 52 Week Low | $1.63 | |||
| Day High | $9.38 | P/E | N/A | |||
| Day Low | $9.38 | EPS | $-0.68 | |||
| Volume | 12 | |||||
